Immunogenicity of trivalent seasonal influenza vaccine in patients with chronic obstructive pulmonary disease

Immunogenicity of trivalent seasonal influenza vaccine in patients with chronic obstructive pulmonary disease

Objective: Current evidence on the immunogenicity of influenza vaccination in patients with chronic obstructive pulmonary disease (COPD) is limited. To address this need for additional knowledge, we conducted a study on the immunogenicity of trivalent seasonal influenza vaccine (TIV) in COPD patient...

Full description

Bibliographic Details
Main Authors: Yan Li, Ying Ma, Zhijie An, Chenyan Yue, Yamin Wang, Yunqiu Liu, Xiaodong Yuan, Shuping Zhang, Ming Shao, Changgui Li, Keli Li, Zundong Yin, Liye Wang, Huaqing Wang
Format: Article
Language:English
Published: Taylor & Francis Group 2021-09-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
immunogenicity
safety
trivalent seasonal influenza vaccine
chronic obstructive pulmonary disease
Online Access:http://dx.doi.org/10.1080/21645515.2021.1911515

Internet

http://dx.doi.org/10.1080/21645515.2021.1911515

Similar Items